| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome P-450 CYP3A | 8 | 2015 | 88 | 2.040 |
Why?
|
| Microsomes, Liver | 9 | 2017 | 119 | 1.540 |
Why?
|
| Isoniazid | 4 | 2016 | 72 | 1.460 |
Why?
|
| Aldehydes | 3 | 2015 | 46 | 1.340 |
Why?
|
| Antitubercular Agents | 5 | 2016 | 350 | 1.310 |
Why?
|
| Cytochrome P-450 Enzyme System | 4 | 2017 | 210 | 1.150 |
Why?
|
| Ritonavir | 3 | 2011 | 65 | 1.100 |
Why?
|
| HIV Protease Inhibitors | 3 | 2017 | 74 | 0.850 |
Why?
|
| Metabolomics | 12 | 2017 | 507 | 0.810 |
Why?
|
| Chemical and Drug Induced Liver Injury | 5 | 2016 | 204 | 0.800 |
Why?
|
| Liver | 9 | 2017 | 3126 | 0.780 |
Why?
|
| Acetaminophen | 4 | 2013 | 126 | 0.570 |
Why?
|
| Receptors, Melatonin | 1 | 2016 | 8 | 0.550 |
Why?
|
| Xenobiotics | 2 | 2018 | 43 | 0.530 |
Why?
|
| Acetamides | 1 | 2016 | 113 | 0.500 |
Why?
|
| Homeostasis | 5 | 2017 | 960 | 0.480 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 221 | 0.460 |
Why?
|
| Saquinavir | 1 | 2013 | 6 | 0.460 |
Why?
|
| Receptors, Steroid | 2 | 2013 | 356 | 0.460 |
Why?
|
| Quinazolines | 2 | 2017 | 953 | 0.460 |
Why?
|
| Liver Diseases | 1 | 2019 | 605 | 0.460 |
Why?
|
| Pyridines | 2 | 2010 | 1311 | 0.430 |
Why?
|
| Metabolome | 3 | 2011 | 355 | 0.420 |
Why?
|
| Lopinavir | 1 | 2011 | 9 | 0.400 |
Why?
|
| Bile Acids and Salts | 6 | 2016 | 261 | 0.400 |
Why?
|
| Rifampin | 1 | 2013 | 220 | 0.390 |
Why?
|
| Monoterpenes | 1 | 2011 | 11 | 0.390 |
Why?
|
| Hydrazones | 1 | 2011 | 43 | 0.380 |
Why?
|
| Clozapine | 1 | 2011 | 26 | 0.380 |
Why?
|
| Hepatocytes | 5 | 2016 | 350 | 0.370 |
Why?
|
| Mice | 28 | 2019 | 35992 | 0.370 |
Why?
|
| Protease Inhibitors | 1 | 2011 | 214 | 0.360 |
Why?
|
| Pyrones | 1 | 2010 | 10 | 0.360 |
Why?
|
| Cholesterol | 3 | 2019 | 678 | 0.350 |
Why?
|
| Biotransformation | 3 | 2016 | 98 | 0.340 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2011 | 132 | 0.340 |
Why?
|
| Feces | 4 | 2016 | 863 | 0.320 |
Why?
|
| Hydrazines | 1 | 2010 | 214 | 0.320 |
Why?
|
| Glutathione | 3 | 2017 | 377 | 0.320 |
Why?
|
| Oligopeptides | 1 | 2010 | 452 | 0.310 |
Why?
|
| Cytochrome P-450 CYP3A Inhibitors | 3 | 2015 | 28 | 0.310 |
Why?
|
| Recombinant Proteins | 5 | 2017 | 3075 | 0.310 |
Why?
|
| Animals | 31 | 2019 | 62771 | 0.300 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 432 | 0.280 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2018 | 337 | 0.270 |
Why?
|
| Protoporphyrins | 2 | 2016 | 10 | 0.250 |
Why?
|
| Atazanavir Sulfate | 2 | 2017 | 7 | 0.240 |
Why?
|
| Carnitine | 2 | 2016 | 87 | 0.240 |
Why?
|
| Membrane Proteins | 1 | 2015 | 2953 | 0.240 |
Why?
|
| Dealkylation | 3 | 2014 | 4 | 0.240 |
Why?
|
| Mice, Knockout | 7 | 2018 | 5837 | 0.230 |
Why?
|
| Oxidation-Reduction | 3 | 2016 | 718 | 0.230 |
Why?
|
| Isoenzymes | 2 | 2016 | 663 | 0.220 |
Why?
|
| Drug Overdose | 2 | 2013 | 97 | 0.210 |
Why?
|
| Cytochrome P-450 CYP2C8 | 2 | 2014 | 5 | 0.210 |
Why?
|
| Cytochrome P-450 CYP2C19 | 2 | 2014 | 20 | 0.210 |
Why?
|
| Liver Regeneration | 2 | 2013 | 134 | 0.210 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2014 | 82 | 0.200 |
Why?
|
| Molecular Structure | 2 | 2015 | 536 | 0.190 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2018 | 641 | 0.190 |
Why?
|
| Hydroxylation | 2 | 2011 | 60 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 12 | 2019 | 7216 | 0.180 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2010 | 83 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 4956 | 0.170 |
Why?
|
| Mice, Inbred ICR | 2 | 2016 | 246 | 0.160 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2018 | 19 | 0.160 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2018 | 48 | 0.160 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2010 | 593 | 0.160 |
Why?
|
| Butyrates | 1 | 2018 | 58 | 0.160 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2018 | 39 | 0.150 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2018 | 104 | 0.150 |
Why?
|
| Naphthalimides | 1 | 2017 | 14 | 0.150 |
Why?
|
| Proglucagon | 1 | 2017 | 7 | 0.150 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2018 | 121 | 0.150 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2018 | 71 | 0.150 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2018 | 154 | 0.150 |
Why?
|
| Response Elements | 1 | 2018 | 200 | 0.150 |
Why?
|
| Fluorometry | 1 | 2017 | 35 | 0.150 |
Why?
|
| Endoribonucleases | 1 | 2018 | 110 | 0.140 |
Why?
|
| Fibronectins | 1 | 2017 | 211 | 0.140 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2017 | 60 | 0.140 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2017 | 74 | 0.140 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2016 | 17 | 0.140 |
Why?
|
| Phospholipase D | 1 | 2016 | 27 | 0.140 |
Why?
|
| Glucose | 3 | 2017 | 1249 | 0.140 |
Why?
|
| Vitamin B 6 | 1 | 2016 | 19 | 0.140 |
Why?
|
| Cysteamine | 1 | 2016 | 14 | 0.140 |
Why?
|
| Cystinosis | 1 | 2016 | 15 | 0.140 |
Why?
|
| Drug Delivery Systems | 2 | 2018 | 662 | 0.140 |
Why?
|
| Leucine | 1 | 2018 | 381 | 0.140 |
Why?
|
| Semicarbazides | 1 | 2016 | 4 | 0.140 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2016 | 37 | 0.140 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2016 | 97 | 0.140 |
Why?
|
| Humans | 26 | 2019 | 270946 | 0.140 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2016 | 157 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2016 | 4182 | 0.140 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2015 | 10 | 0.130 |
Why?
|
| Imines | 1 | 2015 | 14 | 0.130 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2015 | 17 | 0.130 |
Why?
|
| Bufanolides | 1 | 2015 | 20 | 0.130 |
Why?
|
| Glycochenodeoxycholic Acid | 1 | 2015 | 8 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2018 | 843 | 0.130 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2015 | 14 | 0.130 |
Why?
|
| Jaundice, Obstructive | 1 | 2015 | 17 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 467 | 0.120 |
Why?
|
| Lithocholic Acid | 1 | 2014 | 3 | 0.120 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 139 | 0.120 |
Why?
|
| Fatty Liver | 1 | 2016 | 257 | 0.120 |
Why?
|
| Benzimidazoles | 1 | 2017 | 441 | 0.120 |
Why?
|
| Mice, Inbred Strains | 2 | 2017 | 570 | 0.120 |
Why?
|
| Diarylquinolines | 1 | 2014 | 22 | 0.120 |
Why?
|
| Prodrugs | 1 | 2015 | 226 | 0.110 |
Why?
|
| Swine | 1 | 2018 | 1610 | 0.110 |
Why?
|
| Antidotes | 1 | 2013 | 27 | 0.110 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 1312 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 14679 | 0.110 |
Why?
|
| Stress, Physiological | 1 | 2016 | 493 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 320 | 0.110 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2015 | 385 | 0.110 |
Why?
|
| Macrophages | 1 | 2019 | 1368 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 487 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2013 | 139 | 0.110 |
Why?
|
| Heme | 1 | 2013 | 83 | 0.100 |
Why?
|
| Principal Component Analysis | 2 | 2010 | 218 | 0.100 |
Why?
|
| Alkaline Phosphatase | 1 | 2013 | 218 | 0.100 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 4371 | 0.100 |
Why?
|
| Alanine Transaminase | 1 | 2013 | 240 | 0.100 |
Why?
|
| Signal Transduction | 4 | 2018 | 12206 | 0.100 |
Why?
|
| Male | 16 | 2019 | 128453 | 0.100 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 440 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2017 | 748 | 0.100 |
Why?
|
| Amino Acids, Essential | 1 | 2011 | 26 | 0.100 |
Why?
|
| Atherosclerosis | 1 | 2019 | 954 | 0.100 |
Why?
|
| Cornea | 1 | 2016 | 681 | 0.100 |
Why?
|
| Ketoconazole | 1 | 2010 | 36 | 0.090 |
Why?
|
| Sophora | 1 | 2010 | 1 | 0.090 |
Why?
|
| Kynuramine | 1 | 2010 | 1 | 0.090 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 1019 | 0.090 |
Why?
|
| Animal Structures | 1 | 2010 | 9 | 0.090 |
Why?
|
| Cytochrome P-450 CYP2D6 Inhibitors | 1 | 2010 | 5 | 0.090 |
Why?
|
| Autophagy | 1 | 2016 | 920 | 0.090 |
Why?
|
| Mitochondria | 2 | 2016 | 1318 | 0.090 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 63 | 0.090 |
Why?
|
| Biocatalysis | 1 | 2010 | 64 | 0.090 |
Why?
|
| Melatonin | 1 | 2010 | 56 | 0.090 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2010 | 43 | 0.090 |
Why?
|
| Inflammation | 2 | 2016 | 2527 | 0.080 |
Why?
|
| Neutrophils | 1 | 2014 | 870 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2017 | 761 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 2261 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2010 | 586 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2010 | 948 | 0.080 |
Why?
|
| Hep G2 Cells | 2 | 2019 | 147 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2010 | 390 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 2368 | 0.070 |
Why?
|
| Energy Metabolism | 3 | 2017 | 1005 | 0.070 |
Why?
|
| Antioxidants | 1 | 2010 | 521 | 0.070 |
Why?
|
| Anti-HIV Agents | 1 | 2010 | 352 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2015 | 2379 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2019 | 2906 | 0.070 |
Why?
|
| Immunotherapy | 1 | 2019 | 3532 | 0.060 |
Why?
|
| Oxygen Consumption | 2 | 2017 | 422 | 0.060 |
Why?
|
| Biomarkers | 2 | 2015 | 5106 | 0.060 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 1347 | 0.060 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 7461 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 1985 | 0.050 |
Why?
|
| Mass Spectrometry | 2 | 2016 | 730 | 0.050 |
Why?
|
| Necrosis | 2 | 2015 | 603 | 0.050 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 499 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2016 | 5782 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2010 | 1919 | 0.040 |
Why?
|
| Mice, Knockout, ApoE | 1 | 2019 | 7 | 0.040 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2019 | 29 | 0.040 |
Why?
|
| Liver X Receptors | 1 | 2019 | 28 | 0.040 |
Why?
|
| Cell Survival | 2 | 2016 | 3081 | 0.040 |
Why?
|
| THP-1 Cells | 1 | 2019 | 54 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 58 | 0.040 |
Why?
|
| Oxazines | 1 | 2018 | 41 | 0.040 |
Why?
|
| Valerates | 1 | 2018 | 11 | 0.040 |
Why?
|
| Cytochrome P-450 CYP2B6 | 1 | 2018 | 20 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 5108 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2019 | 215 | 0.040 |
Why?
|
| Cell Proliferation | 3 | 2016 | 7294 | 0.040 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2018 | 102 | 0.040 |
Why?
|
| Cytochromes | 1 | 2017 | 10 | 0.040 |
Why?
|
| Receptors, Glucagon | 1 | 2017 | 38 | 0.040 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 72 | 0.040 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 114 | 0.040 |
Why?
|
| Glucagon | 1 | 2017 | 202 | 0.040 |
Why?
|
| Kidney Tubules | 1 | 2017 | 145 | 0.040 |
Why?
|
| Chimera | 1 | 2017 | 152 | 0.040 |
Why?
|
| Cell Line, Tumor | 3 | 2018 | 14864 | 0.040 |
Why?
|
| Membrane Lipids | 1 | 2016 | 48 | 0.040 |
Why?
|
| Alkalies | 1 | 2016 | 29 | 0.040 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2017 | 74 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 223 | 0.030 |
Why?
|
| Cystine | 1 | 2016 | 33 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 229 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 117 | 0.030 |
Why?
|
| Lipid Droplets | 1 | 2016 | 56 | 0.030 |
Why?
|
| Ophthalmic Solutions | 1 | 2016 | 96 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2017 | 294 | 0.030 |
Why?
|
| Exhalation | 1 | 2016 | 61 | 0.030 |
Why?
|
| Female | 7 | 2018 | 148508 | 0.030 |
Why?
|
| Phospholipids | 1 | 2016 | 171 | 0.030 |
Why?
|
| Pyridones | 1 | 2018 | 362 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2017 | 594 | 0.030 |
Why?
|
| Keratin-18 | 1 | 2015 | 10 | 0.030 |
Why?
|
| HMGB1 Protein | 1 | 2015 | 40 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 747 | 0.030 |
Why?
|
| Fasting | 1 | 2016 | 350 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 744 | 0.030 |
Why?
|
| NADPH Oxidase 2 | 1 | 2014 | 43 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 254 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 203 | 0.030 |
Why?
|
| Lysosomes | 1 | 2016 | 347 | 0.030 |
Why?
|
| Transfection | 1 | 2019 | 3172 | 0.030 |
Why?
|
| Kinetics | 1 | 2017 | 2247 | 0.030 |
Why?
|
| Bile | 1 | 2014 | 85 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2018 | 567 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2018 | 687 | 0.030 |
Why?
|
| Cholestyramine Resin | 1 | 2013 | 17 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2017 | 1719 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 145 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 519 | 0.030 |
Why?
|
| Species Specificity | 1 | 2015 | 809 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2018 | 16186 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 537 | 0.030 |
Why?
|
| Genes, jun | 1 | 2012 | 42 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2016 | 907 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2013 | 6483 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 1287 | 0.030 |
Why?
|
| DNA Primers | 1 | 2015 | 1508 | 0.030 |
Why?
|
| Receptors, Immunologic | 1 | 2014 | 316 | 0.030 |
Why?
|
| Methylation | 1 | 2014 | 626 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2012 | 94 | 0.030 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 155 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2016 | 2314 | 0.030 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2014 | 142 | 0.020 |
Why?
|
| Cholestasis | 1 | 2014 | 207 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 263 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2012 | 212 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2015 | 1855 | 0.020 |
Why?
|
| Insulin | 1 | 2017 | 1510 | 0.020 |
Why?
|
| Caspases | 1 | 2014 | 698 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2012 | 342 | 0.020 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 272 | 0.020 |
Why?
|
| Genes, myc | 1 | 2012 | 373 | 0.020 |
Why?
|
| Herb-Drug Interactions | 1 | 2010 | 1 | 0.020 |
Why?
|
| Quinolizines | 1 | 2010 | 11 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 2214 | 0.020 |
Why?
|
| Alkaloids | 1 | 2010 | 83 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 589 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2010 | 262 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 15849 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 1212 | 0.020 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 1571 | 0.020 |
Why?
|
| Piperazines | 1 | 2018 | 2153 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 4109 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 1107 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 3920 | 0.020 |
Why?
|
| Intestines | 1 | 2013 | 731 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 887 | 0.020 |
Why?
|
| Base Sequence | 1 | 2015 | 5496 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 3648 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 2465 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 2264 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2013 | 826 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2013 | 1124 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 2465 | 0.020 |
Why?
|
| Diet | 1 | 2014 | 1484 | 0.020 |
Why?
|
| Hepatectomy | 1 | 2012 | 1012 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 2093 | 0.020 |
Why?
|
| Adult | 1 | 2011 | 81555 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2012 | 4985 | 0.010 |
Why?
|
| Gene Expression | 1 | 2012 | 3681 | 0.010 |
Why?
|
| Middle Aged | 1 | 2011 | 90020 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2010 | 1158 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 7813 | 0.010 |
Why?
|
| Cell Line | 1 | 2010 | 5437 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 13112 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 33827 | 0.010 |
Why?
|